Company Snapshot: Nemaura Medical Inc.

NMRD
Last	Change	Volume	High	Low

Company Overview

Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes specialty medical devices. It provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as for screening pre-diabetic patients. The company was founded in 2009 and is headquartered in Loughborough, the United Kingdom.

Client News

1. May 20 2020 Nemaura Medical 2020 Stock Incentive Plan Approved at Annual General Meeting
2. May 11 2020 Nemaura reports positive data from early head-to-head comparison with a major incumbent CGM Device
3. May 5 2020 Nemaura Medical Announces Interview with CEO to Air on May 11
4. Apr 21 2020  Nemaura Secures $5 Million Loan to Accelerate Commercial Strategy